Literature DB >> 7608166

Ligand binding analysis of soluble interleukin-2 receptor complexes by surface plasmon resonance.

Z Wu1, K W Johnson, Y Choi, T L Ciardelli.   

Abstract

Knowledge of the kinetic binding characteristics is often critical to the development of ligand/receptor structure-activity relationships. To better understand the contribution of each of the subunits to ligand binding in the multimeric interleukin-2 receptor system, we have previously prepared stable solution complexes of the alpha- and beta-subunits. In this study, we have employed surface plasmon resonance biosensor methodology (BIAcore) to evaluate both the kinetic and equilibrium binding constants for these complexes. The structural nature of the complexes facilitated immobilization on the sensor surfaces in a manner that minimized interference with ligand interactions. The interleukin-2 receptor complex surfaces displayed excellent binding capacity and stability toward regeneration. In all cases where the binding constants were measurable, the values determined for interleukin-2 were in good agreement with those previously determined by other methods. When interleukin-2 analogs with receptor subunit specific mutations were employed, the binding parameters were consistent with the nature of the mutations. The combination of coiled-coil-mediated solution assembly and surface plasmon resonance analysis of ligand binding provides a powerful approach to the study of multimeric cytokine receptor systems.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608166     DOI: 10.1074/jbc.270.27.16045

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Solution assembly of the pseudo-high affinity and intermediate affinity interleukin-2 receptor complexes.

Authors:  Z Wu; B Goldstein; T M Laue; S F Liparoto; M J Nemeth; T L Ciardelli
Journal:  Protein Sci       Date:  1999-03       Impact factor: 6.725

2.  Analysis of a peptide hormone-receptor interaction in the yeast two-hybrid system.

Authors:  J Zhu; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

3.  Kinetic analysis of ligand binding to interleukin-2 receptor complexes created on an optical biosensor surface.

Authors:  D G Myszka; P R Arulanantham; T Sana; Z Wu; T A Morton; T L Ciardelli
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

4.  The effect of covalently immobilized rhIL-1ra-ELP fusion protein on the inflammatory profile of LPS-stimulated human monocytes.

Authors:  Dong-Hwan Kim; Jason T Smith; Ashutosh Chilkoti; William M Reichert
Journal:  Biomaterials       Date:  2007-04-12       Impact factor: 12.479

5.  Kinetic analysis of cytokine-mediated receptor assembly using engineered FC heterodimers.

Authors:  Ashlesha Deshpande; Balananda-Dhurjati Kumar Putcha; Srilalitha Kuruganti; Mark R Walter
Journal:  Protein Sci       Date:  2013-06-06       Impact factor: 6.725

6.  Structural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.

Authors:  Timothy F Fernandez; Alexandra B Samal; Gregory J Bedwell; Yabing Chen; Jamil S Saad
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

7.  IL-2Rβ abundance differentially tunes IL-2 signaling dynamics in CD4+ and CD8+ T cells.

Authors:  Geoffrey A Smith; Jack Taunton; Arthur Weiss
Journal:  Sci Signal       Date:  2017-12-19       Impact factor: 8.192

8.  The structure of IL2 bound to the three chains of the IL2 receptor and how signaling occurs.

Authors:  Kendall A Smith
Journal:  Med Immunol       Date:  2006-08-14

Review 9.  Structural biology of shared cytokine receptors.

Authors:  Xinquan Wang; Patrick Lupardus; Sherry L Laporte; K Christopher Garcia
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

10.  Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy.

Authors:  Deborah Charych; Samira Khalili; Vidula Dixit; Peter Kirk; Thomas Chang; John Langowski; Werner Rubas; Stephen K Doberstein; Michael Eldon; Ute Hoch; Jonathan Zalevsky
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.